Skip to main content

Advertisement

Log in

Perspectives on overactive bladder in the elderly population

  • Topic Paper
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Introduction

Overactive bladder (OAB) represents a disruption in the storage function of the lower urinary tract. This bothersome condition occurs more commonly in the elderly. Since population forecasts predict a worldwide increase in the proportion of people aged over 65 years, it is reasonable to expect that the healthcare burden associated with OAB will also increase. The pathophysiology of OAB in the elderly is thought to be multifactorial, with an abnormality occurring in the nervous supply and/or the structure/function of the urothelium or bladder smooth muscle, leading to bladder hypersensitivity, abnormalities in bladder sensation (urgency) and involuntary detrusor contraction.

Methods

A review of some of the key aspects relating to management of this growing population was undertaken.

Results

The potential for an elderly patient to present with a number of concomitant conditions means that careful characterization of their overall status is required before deciding on the most appropriate management option for their urinary tract pathology. Lifestyle interventions and pharmacological agents have shown success in treating OAB in the elderly, but as this patient group often has many concomitant conditions they are more likely to be seen by a non-urology specialist.

Conclusions

It is therefore important to raise awareness of the condition and an appreciation of its impact among healthcare professionals to ensure the most appropriate care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 21:167–178

    Article  PubMed  Google Scholar 

  2. United Nations World Population Prospects, 2006 Revision. http://esa.un.org/unpp/index.asp

  3. Stewart WF, Van Rooyen JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20(6):327–336

    CAS  PubMed  Google Scholar 

  4. Irwin DE, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50(6):1306–1315

    Article  PubMed  Google Scholar 

  5. Abrams P, Cardozo L, Fall M et al (2003) The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Urology 61(1):37–49

    Article  PubMed  Google Scholar 

  6. Homma Y, Yamaguchi O, Hayashi K et al (2005) An epidemiologic survey of overactive bladder symptoms in Japan. BJU Int 96:1314–1318

    Article  PubMed  Google Scholar 

  7. Abrams P, Kelleher CJ, Kerr LA et al (2000) Overactive bladder significantly affects quality of life. Am J Manage Care 6(Suppl 11):S580–S590

    CAS  Google Scholar 

  8. Coyne KS, Payne C, Bhattacharyya SK et al (2004) The impact of urinary urgency and frequency on health related quality of life in overactive bladder: results from a national community survey. Value Health 7:455–463

    Article  PubMed  Google Scholar 

  9. Currie CJ, McEwan P, Poole CD et al (2006) The impact of the overactive bladder on health-related utility and quality of life. BJU Int 97:1267–1272

    Article  PubMed  Google Scholar 

  10. Wagg A, Cohen M (2002) Medical therapy for the overactive bladder in the elderly. Age Ageing 31:241–246

    Article  PubMed  Google Scholar 

  11. Thom DH, Haan MN, Van Den Eeden SK (1997) Medically recognised urinary incontinence and risks of hospitalisation, nursing home admission and mortality. Age Aging 26:367–374

    Article  CAS  Google Scholar 

  12. DuBeau C (2008) 4th international consultation on incontinence 2008; incontinence in the frail elderly

  13. Wagner TH, Hu TW, Bentkover J et al (2002) Health related consequences of overactive bladder. Am J Manage Care 6(Suppl 19):S598–S607

    Google Scholar 

  14. Brown JS, McGhan WF, Chokroverty S (2000) Comorbidities associated with overactive bladder. Am J Manage Care 6(Suppl 1):S574–S579

    CAS  Google Scholar 

  15. Wong SYS, Hong A, Leung J et al (2006) Lower urinary tract symptoms and depressive symptoms in elderly men. J Affect Disord 96:83–88

    Article  PubMed  Google Scholar 

  16. Engstrom G, Henningsohn L, Walker-Engstrom ML et al (2006) Impact on quality of life of different lower urinary tract symptoms in men measured by the short form SF-36 questionnaire. Scan J Urol Nephrol 40:485–494

    Article  Google Scholar 

  17. Homma Y, Yamaguchi O, Hayashi K, the members of the Neurogenic Bladder Society committee (2006) Epidemiologic survey of lower urinary tract symptoms in Japan. Urology 68:560–564

    Article  PubMed  Google Scholar 

  18. Milsom I, Abrams P, Cardozo L et al (2001) How widespread are the symptoms of overactive bladder and how are they managed? A population based prevalence study. BJU Int 87:760–766

    Article  CAS  PubMed  Google Scholar 

  19. Shaw C, Tansey R, Jackson C et al (2001) Barriers to help seeking in people with urinary symptoms. Fam Pract 18:48–52

    Article  CAS  PubMed  Google Scholar 

  20. Teunissen D, van den Bosch W, van Weel C et al (2006) Urinary incontinence in the elderly: attitudes and experiences of general practitioners. Scan J Prim Health Care 24:56–61

    Article  Google Scholar 

  21. Yoshida M, Inadome A, Matsumoto K et al (2009) Overactive bladder in female patients with chronic diseases visiting primary care doctors: effect of age on prevalence and bothersomeness. LUTS 1:45–50

    Google Scholar 

  22. McGrother CW, Donaldson MMK, Shaw C, Matthews RJ, Hayward TA, Dallosso HM et al (2004) Storage symptoms of the bladder: prevalence, incidence and need for services in the UK. BJU Int 93:763–769

    Article  CAS  PubMed  Google Scholar 

  23. Robinson D, Anders K, Cardozo L et al (2007) Outcome measures in urogynecology: the clinician’s perspective. Int Urogynecol J 18:273–279

    Article  Google Scholar 

  24. Kelleher CJ, Cardozo LD, Khullar V et al (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 104:1374–1379

    CAS  PubMed  Google Scholar 

  25. Brading AF (1997) A myogenic basis for the overactive bladder. Urology 50:57–67

    Article  CAS  PubMed  Google Scholar 

  26. Resnick NM, Yalla SV (1987) Detrusor hyperactivity with impaired contractile function. An unrecognized but common source of incontinence in elderly patients. JAMA 257:3076–3081

    Article  CAS  PubMed  Google Scholar 

  27. Griffiths DJ et al (1994) Cerebral aetiology of urinary urge incontinence in elderly people. Age Ageing 23:246–250

    Article  CAS  PubMed  Google Scholar 

  28. Kitada S et al (1992) Bladder function in elderly men with subclinical brain magnetic resonance imaging lesions. J Urol 147:1507–1509

    CAS  PubMed  Google Scholar 

  29. Elbadawi A, Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. II. Aging detrusor: normal versus impaired contractility. J Urol 150:1657–1667

    CAS  PubMed  Google Scholar 

  30. Elbadawi A, Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity. J Urol 150:1668–1680

    CAS  PubMed  Google Scholar 

  31. Elbadawi A, Yalla SV, Resnick NM (1993) Structural basis of geriatric voiding dysfunction. IV. Bladder outlet obstruction. J Urol 150:1681–1695

    CAS  PubMed  Google Scholar 

  32. Carey MP, de Jong S, Dwyer P et al (1998) Impaired detrusor contractility in women—is there a morphological basis? Neurourol Urodyn 17:308–309

    Google Scholar 

  33. Kohan AD et al (2000) Effect of aging on bladder function and the response to outlet obstruction in female rats. Urol Res 28:33–37

    Article  CAS  PubMed  Google Scholar 

  34. Frazier EP, Schneider T, Michel MC (2006) Effects of gender, age and hypertension on β-adrenergic receptor function in rat urinary bladder. Naunyn Schmiedeberg’s Arch Pharmacol 373:300–309

    Article  CAS  Google Scholar 

  35. Hegde SS, Mandel DA, Wilford MR et al (1998) Evidence for purinergic neurotransmission in the urinary bladder of pithed rats. Eur J Pharmacol 349:75–82

    Article  CAS  PubMed  Google Scholar 

  36. Kolta MG, Wallace LJ, Gerald MC (1984) Age-related changes in sensitivity of rat urinary bladder to autonomic agents. Mech Ageing Dev 27:183–188

    Google Scholar 

  37. Lagou M, Gillespie J, Kirkwood T et al (2006) Muscarinic stimulation of the mouse isolated whole bladder: physiological responses in young and ageingmice. Auton Autacoid Pharmacol 26:253–260

    Article  CAS  PubMed  Google Scholar 

  38. Lai HH, Bonne TB, Thompson TC et al (2007) Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder. Urology 69:407–411

    Article  PubMed  Google Scholar 

  39. Lluel P, Deplanne V, Heudes D, Bruneval P, Palea S (2003) Age related changes in urethrovesical coordination in male rats: Relationship with bladder instability? Am J Physiol Regul Integr Comp Physiol 284:R1287–R1295

    Google Scholar 

  40. Lluel P, Palea S, Barras M et al (2000) Functional and morphological modifications of the urinary bladder in aging female rats. Am J Physiol 278:R964–R972

    CAS  Google Scholar 

  41. Ordway GA, Esbenshade TA, Kolta MG et al (1986) Effect of age on cholinergic muscarinic responsiveness and receptors in the rat urinary bladder. J Urol 136:492–496

    CAS  PubMed  Google Scholar 

  42. Ordway GA, Kolta MG, Gerald MC et al (1986) Age-related change in α-adrenergic responsiveness of the urinary bladder of the rat is regionally specific. Neuropharmacol 25:1335–1340

    Article  CAS  Google Scholar 

  43. Pagala MK, Tetsoti L, Nagpal D et al (2001) Aging effects on contractility of longitudinal and circular detrusor and trigone of rat bladder. J Urol 166:721–727

    Article  CAS  PubMed  Google Scholar 

  44. Schneider T, Hein P, Michel-Reher M et al (2005) Effects of ageing on muscarinic receptor subtypes and function in rat urinary bladder. Naunyn Schmiedeberg’s Arch Pharmacol 372:71–78

    Article  CAS  Google Scholar 

  45. Wuest M, Morgenstern K, Graf EM et al (2005) Cholinergic and purinergic responses in isolated human detrusor in relation to age. J Urol 173:2182–2189

    Article  CAS  PubMed  Google Scholar 

  46. Yu HJ, Wein AJ, Levin RM (1997) Contractile responses and calcium mobilization induced by muscarinic agonists in the rat urinary bladder: effects of age. Gen Pharmacol 28:623–628

    CAS  PubMed  Google Scholar 

  47. Braverman AS, Luthin GR, Ruggieri MR (1998) M2 muscarinic receptor contributes to contraction of the denervated rat urinary bladder. Am J Physiol 275:R1654–R1660

    CAS  PubMed  Google Scholar 

  48. Braverman AS, Legos JJ, Young W et al (1999) M2 receptors in genito-urinary smooth muscle pathology. Life Sci 64:429–436

    Article  CAS  PubMed  Google Scholar 

  49. Ruggieri MR Sr, Braverman AS (2006) Regulation of bladder muscarinic receptor subtypes by experimental pathologies. Auton Autacoid Pharmacol 26:311–325

    Article  CAS  PubMed  Google Scholar 

  50. Latifpour J, Kondo S, O’Hollaren B et al (1990) Autonomic receptors in urinary tract: sex and age differences. J Pharmacol Exp Ther 253:661–667

    CAS  PubMed  Google Scholar 

  51. Mansfield KJ, Liu L, Mitchelson FJ et al (2005) Muscarinic receptor subtypes in human bladder detrusor and mucosa, studied by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol 144:1089–1099

    Google Scholar 

  52. Lluel P, Salea S, Rbiere P et al (2003) Increased adrenergic contractility and decreased mRNA expression of NOS III in aging rat urinary bladders. Fundam Clin Pharmacol 17:633–641

    Article  CAS  PubMed  Google Scholar 

  53. Takahashi S, Moriyama N, Yamazaki R et al (1996) Urodynamic analysis of age-related changes of 1-adrenoceptor responsiveness in female beagle dogs. J Urol 156:1485–1488

    Article  CAS  PubMed  Google Scholar 

  54. Nishimoto T, Latifpour J, Wheeler MA et al (1995) Age-dependent alterations in b-adrenergic responsiveness of rat detrusor smooth muscle. J Urol 153:1701–1705

    Article  CAS  PubMed  Google Scholar 

  55. Li G, Li K, Li Z et al (2003) Age-dependent changes in β-adrenoceptor function in human detrusor and possible mechanisms. Chin Med J 116:1511–1514

    CAS  PubMed  Google Scholar 

  56. Yoshida M, Homma Y, Inadome A et al (2001) Age-related changes in cholinergic and purinergic neurotransmission in human isolated bladder smooth muscles. Exp Gerontol 36:99–109

    Article  CAS  PubMed  Google Scholar 

  57. Bayliss M, Wu C, Newgreen D et al (1999) A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders. J Urol 162:1833

    Article  CAS  PubMed  Google Scholar 

  58. Zinner NR, Mattiasson A, Stanton SL (2002) Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients. J Am Geriatr Soc 50:799–807

    Article  PubMed  Google Scholar 

  59. Foote JE (2004) Darifenacin, an M3 selective receptor antagonist (M3 SRA), is effective and well tolerated in elderly patients with overactive bladder. J Am Geriatr Soc 52(S1):A321

    Google Scholar 

  60. Chapple CR, Cardozo L, Steers WD et al (2006) Solifenacin significantly improves all symptoms of overactive bladder syndrome. Int J Clin Pract 60:959–966

    Article  CAS  PubMed  Google Scholar 

  61. Wagg A, Wyndaele JJ, Sieber P (2006) Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. Am J Geriatr Pharmacother 4:14–24

    Article  CAS  PubMed  Google Scholar 

  62. Yoshida M et al (2007) Treatment of overactive bladder: Pharmacological treatment (in Japanese). Jap J Clin Urol 61:611

    Google Scholar 

  63. Yoshida M, Inadome A, Maeda Y et al (2006) Non-neuronal cholinergic system in human bladder urothelium. Urology 67:425–430

    Article  PubMed  Google Scholar 

  64. Hawthorn MH, Chapple CR, Cock M et al (2000) Urothelium derived inhibitory factor(s) influences on detrusor muscle contractility in vitro. Br J Pharmacol 129:416–419

    Article  CAS  PubMed  Google Scholar 

  65. Mansfield KJ, Liu L, Mitchelson FJ et al (2005) Muscarinic receptor subtypes in human bladder detrusor and mucosa, studies by radioligand binding and quantitative competitive RT-PCR: changes in ageing. Br J Pharmacol 144:1089–1099

    Article  CAS  PubMed  Google Scholar 

  66. Mukerji G, Yiangou Y, Grogono J et al (2006) Localisation of M2 and M3 muscarinic receptors in human bladder disorders and their clinical correlations. J Urol 176:367–373

    Article  CAS  PubMed  Google Scholar 

  67. Griffiths DJ, McCracken PN, Harrison GM et al (2002) Urge incontinence and impaired detrusor contractility in the elderly. Neurourol Urodyn 21:126–131

    Article  PubMed  Google Scholar 

  68. Pfisterer MHD, Griffiths DJ, Rosenberg L et al (2006) The impact of detrusor overactivity on bladder function in younger and older women. J Urology 175:1777–1783

    Article  Google Scholar 

  69. Andersson KE, Chapple C, Wein A (2001) The basis for drug treatment of the overactive bladder. World J Urol 19:294–298

    Article  CAS  PubMed  Google Scholar 

  70. Andersson K-E, Appell R, Cardozo L et al (2005) In: Abrams P, Cardozo L, Khoury S, Wein A (eds) 3rd international consultation in incontinence, Monaco, June 26–29, 2005, chap 14, Health Publications Ltd

  71. de Groat WC, Downie JW, Levin RM et al (1999) Basic neurophysiology and neuropharmacology. In: Abrams P, Khoury S, Wein A (eds) Incontinence, 1st international consultation on incontinence, Plymouth, Plymbridge Distributors Ltd, pp 105–154

  72. Matthews F, Brayne C (2005) The incidence of dementia in England and Wales; Findings from the five identical sites of the MRC CFA study. PloS Med 2:753–763

    Google Scholar 

  73. Erdem N, Chu FM (2006) Management of overactive bladder and urge urinary incontinence in the elderly patient. Am J Med 119(3A):295–365

    Google Scholar 

  74. MacDiarmid SA (2008) Maximising the treatment of overactive bladder in the elderly. Rev Urol 10:6–13

    PubMed  Google Scholar 

  75. Staskin DR (2005) Overactive bladder in the elderly—a guide to pharmacological management. Drugs Aging 22:1013–1028

    Article  CAS  PubMed  Google Scholar 

  76. Zinner N, Gittelman M, Harris R et al, for the Trospium Study Group (2004) Trospium chloride improves overactive bladder symptoms: a multicentre phase III trial. J Urol 171:2311–2315

    Google Scholar 

  77. Sand P, Zinner N, Newman D et al (2007) Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community based, randomized study. BJU Int 99:836–844

    Article  CAS  PubMed  Google Scholar 

  78. Kay GG, Granville LJ (2005) Antimuscarinic agents: Implications and concerns in the management of overactive bladder in the elderly. Clin Therapeutics 27:127–136

    Article  CAS  Google Scholar 

  79. Sink KM, Thomas J, Xu H et al (2008) Dual use of bladder anticholinergics and cholinesterase inhibitors: long terms functional and cognitive outcomes. J Am Geriatr Soc 56:847–853

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

MY has received support from and participated in studies with Astellas.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masaki Yoshida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yoshida, M. Perspectives on overactive bladder in the elderly population. World J Urol 27, 729–737 (2009). https://doi.org/10.1007/s00345-009-0491-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-009-0491-0

Keywords

Navigation